GALMED PHARMACEUTICALS LTD. (GLMD) Capital expenditures 2016–2024
GALMED PHARMACEUTICALS LTD. (GLMD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4,000FY2024 · since FY2016: $770,000 → $4,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $4,000 | -63.6% |
| FY2023 | $11,000 | -75.0% |
| FY2022 | $44,000 | +266.7% |
| FY2021 | $12,000 | -86.7% |
| FY2020 | $90,000 | +650.0% |
| FY2019 | $12,000 | -29.4% |
| FY2018 | $17,000 | -89.3% |
| FY2017 | $159,000 | -79.4% |
| FY2016 | $770,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice